Expression library immunization can confer protection against lethal challenge with African swine fever virus

Journal of Virology

Volumn 88, Issue 22, 2014, Pages 13322-13332

  Lacasta, Anna ^a,b   Ballester, María ^a,c   Monteagudo, Paula L ^a   Rodríguez, Javier M ^d   Salas, María L ^e   Accensi, Francesc ^a,f   Pina Pedrero, Sonia ^a,g   Bensaid, Albert ^a   Argilaguet, Jordi ^a,h   López Soria, Sergio ^a   Hutet, Evelyne ⁱ   Le Potier, Marie Frédérique ⁱ   Rodríguez, Fernando ^a  

^a CENTRE DE RECERCA EN SANITAT ANIMAL CRESA   (Spain)

^b INTERNATIONAL LIVESTOCK RESEARCH INSTITUTE   (Kenya)

^c CENTRE FOR RESEARCH IN AGRICULTURAL GENOMICS CRAG   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

^e CSIC   (Spain)

^f UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^g IRTA   (Spain)

^h UNIVERSITAT POMPEU FABRA   (Spain)

ⁱ Agence Nationale de Securite Sanitaire de l'Alimentation de l'Environnement et du Travail (ANSES)   (France)

Author keywords

[No Author keywords available]

Indexed keywords

UBIQUITIN; DNA VACCINE; VIRUS VACCINE;

AFRICAN SWINE FEVER VIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DNA IMMUNIZATION; EXPRESSION LIBRARY IMMUNIZATION; MALE; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; RESTRICTION FRAGMENT; SURVIVAL; SWINE; VIREMIA; VIRUS GENOME; VIRUS SHEDDING; VIRUS STRAIN; VIRUS VIRULENCE; ADMINISTRATION AND DOSAGE; AFRICAN SWINE FEVER; ANIMAL; GENE EXPRESSION; GENE LIBRARY; GENETICS; IMMUNIZATION; IMMUNOLOGY; PIG; PROCEDURES; SURVIVAL ANALYSIS;

AFRICAN SWINE FEVER; AFRICAN SWINE FEVER VIRUS; ANIMALS; GENE EXPRESSION; GENE LIBRARY; IMMUNIZATION; MALE; PLASMIDS; SURVIVAL ANALYSIS; SWINE; VACCINES, DNA; VIRAL VACCINES;

EID: 84908389426     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01893-14     Document Type: Article

References (63)

1. Dixon LK, Abrams CC, Bowick G, Goatley LC, Kay-Jackson PC, Chapman D, Liverani E, Nix R, Silk R, Zhang F. 2004. African swine fever virus proteins involved in evading host defence systems. Vet. Immunol. Immunopathol. 100:117-134. http://dx.doi.org/10.1016/j.vetimm.2004.04.002.
2. Rowlands RJ, Michaud V, Heath L, Hutchings G, Oura C, Vosloo W, Dwarka R, Onashvili T, Albina E, Dixon LK. 2008. African swine fever virus isolate, Georgia, 2007. Emerg. Infect. Dis. 14:1870-1874. http://dx.doi.org/10.3201/eid1412.080591.
3. Jori F, Bastos AD. 2009. Role of wild suids in the epidemiology of African swine fever. Ecohealth 6:296-310. http://dx.doi.org/10.1007/s10393-009-0248-7.
4. Sanchez-Vizcaino JM, Mur L, Martinez-Lopez B. 2012. African swine fever: an epidemiological update. Transbound. Emerg. Dis. 59(Suppl s1): 27-35. http://dx.doi.org/10.1111/j.1865-1682.2011.01293.x.
5. Wardley RC, Norley SG, Wilkinson PJ, Williams S. 1985. The role of antibody in protection against African swine fever virus. Vet. Immunol. Immunopathol. 9:201-212. http://dx.doi.org/10.1016/0165-2427 (85)90071-6.
6. Onisk DV, Borca MV, Kutish G, Kramer E, Irusta P, Rock DL. 1994. Passively transferred African swine fever virus antibodies protect swine against lethal infection. Virology 198:350-354. http://dx.doi.org/10.1006/viro.1994.1040.
7. Escribano JM, Galindo I, Alonso C. 2013. Antibody-mediated neutralization of African swine fever virus: myths and facts. Virus Res. 173:101-109. http://dx.doi.org/10.1016/j.virusres.2012.10.012.
8. Oura CA, Denyer MS, Takamatsu H, Parkhouse RM. 2005. In vivo depletion of CD8+ T lymphocytes abrogates protective immunity to African swine fever virus. J. Gen. Virol. 86:2445-2450. http://dx.doi.org/10.1099/vir.0.81038-0.
9. Takamatsu H, Denyer M, Lacasta A, Stirling C, Argilaguet J, Netherton C, Oura C, Martins C, Rodriguez F. 2012. Cellular immunity in ASFV responses. Virus Res. http://dx.doi.org/10.1016/j.virusres.2012.11.009.
10. Malmquist WA. 1962. Propagation, modification, and hemadsorption of African swine fever virus in cell cultures. Am. J. Vet. Res. 23:241-247.
11. Ruiz Gonzalvo F, Carnero E, Bruvel V. 1983. Immunological responses of pigs to partially attenuated African swine fever virus and their resistance to virulent homologous and heterologous viruses, p 206-216. In Wilkinson PJ (ed), African swine fever. Proceedings of CEC/FAO Research Seminar, Sardinia, September 1981. Publication EUR 8466 EN. Commission of the European Communities, Brussels, Belgium.
12. King K, Chapman D, Argilaguet JM, Fishbourne E, Hutet E, Cariolet R, Hutchings G, Oura CA, Netherton CL, Moffat K, Taylor G, Le Potier MF, Dixon LK, Takamatsu HH. 2011. Protection of European domestic pigs from virulent African isolates of African swine fever virus by experimental immunisation. Vaccine 29:4593-4600. http://dx.doi.org/10.1016/j.vaccine.2011.04.052.
13. Barderas MG, Rodriguez F, Gomez-Puertas P, Aviles M, Beitia F, Alonso C, Escribano JM. 2001. Antigenic and immunogenic properties of a chimera of two immunodominant African swine fever virus proteins. Arch. Virol. 146:1681-1691. http://dx.doi.org/10.1007/s007050170056.
14. Gomez-Puertas P, Rodriguez F, Oviedo JM, Brun A, Alonso C, Escribano JM. 1998. The African swine fever virus proteins p54 and p30 are involved in two distinct steps of virus attachment and both contribute to the antibody-mediated protective immune response. Virology 243:461-471. http://dx.doi.org/10.1006/viro.1998.9068.
15. Ruiz-Gonzalvo F, Coll JM. 1993. Characterization of a soluble hemagglutinin induced in African swine fever virus-infected cells. Virology 196: 769-777. http://dx.doi.org/10.1006/viro.1993.1534.
16. Neilan JG, Zsak L, Lu Z, Burrage TG, Kutish GF, Rock DL. 2004. Neutralizing antibodies to African swine fever virus proteins p30, p54, and p72 are not sufficient for antibody-mediated protection. Virology 319: 337-342. http://dx.doi.org/10.1016/j.virol.2003.11.011.
17. Argilaguet JM, Perez-Martin E, Gallardo C, Salguero FJ, Borrego B, Lacasta A, Accensi F, Diaz I, Nofrarias M, Pujols J, Blanco E, Perez-Filgueira M, Escribano JM, Rodriguez F. 2011. Enhancing DNA immunization by targeting ASFV antigens to SLA-II bearing cells. Vaccine 29: 5379-5385. http://dx.doi.org/10.1016/j.vaccine.2011.05.084.
18. Argilaguet JM, Perez-Martin E, Nofrarias M, Gallardo C, Accensi F, Lacasta A, Mora M, Ballester M, Galindo-Cardiel I, Lopez-Soria S, Escribano JM, Reche PA, Rodriguez F. 2012. DNA vaccination partially protects against African swine fever virus lethal challenge in the absence of antibodies. PLoS One 7:e40942. http://dx.doi.org/10.1371/journal.pone.0040942.
19. Yanez RJ, Rodriguez JM, Nogal ML, Yuste L, Enriquez C, Rodriguez JF, Vinuela E. 1995. Analysis of the complete nucleotide sequence of African swine fever virus. Virology 208:249-278. http://dx.doi.org/10.1006/viro.1995.1149.
20. Blasco R, de la Vega I, Almazan F, Aguero M, Vinuela E. 1989. Genetic variation of African swine fever virus: variable regions near the ends of the viral DNA. Virology 173:251-257. http://dx.doi.org/10.1016/0042-6822(89)90241-9.
21. Chapman DA, Tcherepanov V, Upton C, Dixon LK. 2008. Comparison of the genome sequences of non-pathogenic and pathogenic African swine fever virus isolates. J. Gen. Virol. 89:397-408. http://dx.doi.org/10.1099/vir.0.83343-0.
22. Dixon LK, Chapman DD, Netherton CL, Upton C. 2013. African swine fever virus replication and genomics. Virus Res. 173:3-14. http://dx.doi.org/10.1016/j.virusres.2012.10.020.
23. Ley V, Almendral JM, Carbonero P, Beloso A, Vinuela E, Talavera A. 1984. Molecular cloning of African swine fever virus DNA. Virology 133: 249-257. http://dx.doi.org/10.1016/0042-6822(84)90392-1.
24. Rodriguez F, Slifka MK, Harkins S, Whitton JL. 2001. Two overlapping subdominant epitopes identified by DNA immunization induce protec-tive CD8(+) T-cell populations with differing cytolytic activities. J. Virol. 75:7399-7409. http://dx.doi.org/10.1128/JVI.75.16.7399-7409.2001.
25. Maniatis T, Fritsch EF, Sambrook J. 1982. Molecular cloning a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
26. Galindo-Cardiel I, Ballester M, Solanes D, Nofrarias M, Lopez-Soria S, Argilaguet JM, Lacasta A, Accensi F, Rodriguez F, Segales J. 2013. Standardization of pathological investigations in the framework of experimental ASFV infections. Virus Res. 173:180-190. http://dx.doi.org/10.1016/j.virusres.2012.12.018.
27. Reed LJ, Muench H. 1938. A simple method of estimating fifty per cent endpoint. Am. J. Hyg. 27:493-497.
28. OIE, World Organisation for Animal Health. 2012. Manual of diagnostic tests and vaccines for terrestrial animals 2014. Section 2.8.1. African swine fever. OIE, World Organisation for Animal Health, Paris, France.
29. Talaat RM, El-Bassiouny A, Osman A, Yossif M, Charmy R, Al-Sherbiny M. 2005. Circulating adhesion molecules in patients with different clinical forms of S. mansoni infection. J. Immunol. 12:143-154.
30. Denyer MS, Wileman TE, Stirling CM, Zuber B, Takamatsu HH. 2006. Perforin expression can define CD8 positive lymphocyte subsets in pigs allowing phenotypic and functional analysis of natural killer, cytotoxic T, natural killer T and MHC un-restricted cytotoxic T-cells. Vet. Immunol. Immunopathol. 110:279-292. http://dx.doi.org/10.1016/j.vetimm.2005.10.005.
31. Rodriguez F, Whitton JL. 2000. Enhancing DNA immunization. Virology 268:233-238. http://dx.doi.org/10.1006/viro.2000.0209.
32. Ramiro-Ibanez F, Ortega A, Brun A, Escribano JM, Alonso C. 1996. Apoptosis: a mechanism of cell killing and lymphoid organ impairment during acute African swine fever virus infection. J. Gen. Virol. 77(Part 9):2209-2219. http://dx.doi.org/10.1099/0022-1317-77-9-2209.
33. Barry MA, Howell DP, Andersson HA, Chen JL, Singh RA. 2004. Expression library immunization to discover and improve vaccine antigens. Immunol. Rev. 199:68-83. http://dx.doi.org/10.1111/j.0105-2896.2004.00143.x.
34. Talaat AM, Stemke-Hale K. 2005. Expression library immunization: a road map for discovery of vaccines against infectious diseases. Infect. Immun. 73: 7089-7098. http://dx.doi.org/10.1128/IAI.73.11.7089-7098.2005.
35. Boyle JS, Brady JL, Lew AM. 1998. Enhanced responses to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction. Nature 392:408-411. http://dx.doi.org/10.1038/32932.
36. Rodriguez F, Zhang J, Whitton JL. 1997. DNA immunization: ubiquitination of a viral protein enhances cytotoxic T-lymphocyte induction and antiviral protection but abrogates antibody induction. J. Virol. 71:8497-8503.
37. Rodriguez F, An LL, Harkins S, Zhang J, Yokoyama M, Widera G, Fuller JT, Kincaid C, Campbell IL, Whitton JL. 1998. DNA immunization with minigenes: low frequency of memory cytotoxic T lymphocytes and inefficient antiviral protection are rectified by ubiquitination. J. Virol. 72:5174-5181.
38. Jenson JS, Childerstone A, Takamatsu H, Dixon LK, Parkhouse RM. 2000. The cellular immune recognition of proteins expressed by an African swine fever virus random genomic library. J. Immunol. Methods 242: 33-42. http://dx.doi.org/10.1016/S0022-1759(00)00222-2.
39. Clapperton M, Diack AB, Matika O, Glass EJ, Gladney CD, Mellencamp MA, Hoste A, Bishop SC. 2009. Traits associated with innate and adaptive immunity in pigs: heritability and associations with performance under different health status conditions. Genet. Sel. Evol. 41:54. http://dx.doi.org/10.1186/1297-9686-41-54.
40. Uenishi H, Shinkai H, Morozumi T, Muneta Y, Jozaki K, Kojima-Shibata C, Suzuki E. 2011. Polymorphisms in pattern recognition receptors and their relationship to infectious disease susceptibility in pigs.BMC Proc. 5(Suppl 4):S27. http://dx.doi.org/10.1186/1753-6561-5-S4-S27.
41. Fowler V, Robinson L, Bankowski B, Cox S, Parida S, Lawlor C, Gibson D, O'Brien F, Ellefsen B, Hannaman D, Takamatsu HH, Barnett PV. 2012. A DNA vaccination regime including protein boost and electroporation protects cattle against foot-and-mouth disease. Antiviral Res. 94: 25-34. http://dx.doi.org/10.1016/j.antiviral.2012.02.002.
42. 2-inactivated whole-virus vaccine J. Virol. 86:13735-13744. http://dx.doi.org/10.1128/JVI.02178-12.
43. + T-cell responses is dramatically modified by DNA immunization and is regulated by gamma interferon. J. Virol. 76: 4251-4259. http://dx.doi.org/10.1128/JVI.76.9.4251-4259.2002.
44. Alonso F, Dominguez J, Vinuela E, Revilla Y. 1997. African swine fever virus-specific cytotoxic T lymphocytes recognize the 32 kDa immediate early protein (vp32). Virus Res. 49:123-130. http://dx.doi.org/10.1016/S0168-1702(97)01459-7.
45. Nascimbeni M, Shin EC, Chiriboga L, Kleiner DE, Rehermann B. 2004. Peripheral CD4(+)CD8(+) T cells are differentiated effector memory cells with antiviral functions. Blood 104:478-486. http://dx.doi.org/10.1182/blood-2003-12-4395.
46. Eugenin EA, Osiecki K, Lopez L, Goldstein H, Calderon TM, Berman JW. 2006. CCL2/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: a potential mechanism of HIV-CNS invasion and NeuroAIDS. J. Neurosci. 26:1098-1106. http://dx.doi.org/10.1523/JNEUROSCI.3863-05.2006.
47. Hulst M, Loeffen W, Weesendorp E. 2013. Pathway analysis in blood cells of pigs infected with classical swine fever virus: comparison of pigs that develop a chronic form of infection or recover. Arch. Virol. 158:325-339. http://dx.doi.org/10.1007/s00705-012-1491-8.
48. Tumpey TM, Garcia-Sastre A, Taubenberger JK, Palese P, Swayne DE, Pantin-Jackwood MJ, Schultz-Cherry S, Solorzano A, Van Rooijen N, Katz JM, Basler CF. 2005. Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice. J. Virol. 79:14933-14944. http://dx.doi.org/10.1128/JVI.79.23.14933-14944.2005.
49. Carrasco L, de Lara FC, Martin de las Mulas J, Gomez-Villamandos JC, Perez J, Wilkinson PJ, Sierra MA. 1996. Apoptosis in lymph nodes in acute African swine fever. J. Comp. Pathol. 115:415-428. http://dx.doi.org/10.1016/S0021-9975(96)80075-2.
50. Gomez del Moral M, Ortuno E, Fernandez-Zapatero P, Alonso F, Alonso C, Ezquerra A, Dominguez J. 1999. African swine fever virus infection induces tumor necrosis factor alpha production: implications in pathogenesis. J. Virol. 73:2173-2180.
51. Oura CA, Powell PP, Parkhouse RM. 1998. African swine fever: a disease characterized by apoptosis. J. Gen. Virol. 79(Part 6):1427-1438.
52. Salguero FJ, Sanchez-Cordon PJ, Nunez A, Fernandez de Marco M, Gomez-Villamandos JC. 2005. Proinflammatory cytokines induce lymphocyte apoptosis in acute African swine fever infection. J. Comp. Pathol. 132:289-302. http://dx.doi.org/10.1016/j.jcpa.2004.11.004.
53. Karalyan Z, Zakaryan H, Sargsyan K, Voskanyan H, Arzumanyan H, Avagyan H, Karalova E. 2012. Interferon status and white blood cells during infection with African swine fever virus in vivo. Vet. Immunol. Immunopathol. 145:551-555. http://dx.doi.org/10.1016/j.vetimm.2011.12.013.
54. Chapman DA, Darby AC, Da Silva M, Upton C, Radford AD, Dixon LK. 2011. Genomic analysis of highly virulent Georgia 2007/1 isolate of African swine fever virus. Emerg. Infect. Dis. 17:599-605. http://dx.doi.org/10.3201/eid1704.101283.
55. Correia S, Ventura S, Parkhouse RM. 2013. Identification and utility of innate immune system evasion mechanisms of ASFV. Virus Res. 173:87-100. http://dx.doi.org/10.1016/j.virusres.2012.10.013.
56. Afonso CL, Piccone ME, Zaffuto KM, Neilan J, Kutish GF, Lu Z, Balinsky CA, Gibb TR, Bean TJ, Zsak L, Rock DL. 2004. African swine fever virus multigene family 360 and 530 genes affect host interferon response. J. Virol. 78:1858-1864. http://dx.doi.org/10.1128/JVI.78.4.1858-1864.2004.
57. Neilan JG, Zsak L, Lu Z, Kutish GF, Afonso CL, Rock DL. 2002. Novel swine virulence determinant in the left variable region of the African swine fever virus genome. J. Virol. 76:3095-3104. http://dx.doi.org/10.1128/JVI.76.7.3095-3104.2002.
58. Zsak L, Lu Z, Burrage TG, Neilan JG, Kutish GF, Moore DM, Rock DL. 2001. African swine fever virus multigene family 360 and 530 genes are novel macrophage host range determinants. J. Virol. 75:3066-3076. http://dx.doi.org/10.1128/JVI.75.7.3066-3076.2001.
59. Diez-Rivero CM, Chenlo B, Zuluaga P, Reche PA. 2010. Quantitative modeling of peptide binding to TAP using support vector machine. Proteins 78:63-72. http://dx.doi.org/10.1002/prot.22535.
60. Ceze N, Probst A, Lecomte T, Ohresser M, Paintaud G, Watier H. 2007. Target antigens for therapeutic antibodies in oncology: many candidates, few successes. Bull. Cancer 94:F129-F136.
61. Ivanov V, Efremov EE, Novikov BV, Balyshev VM, Tsibanov S, Kali-novsky T, Kolbasov DV, Niedzwiecki A, Rath M. 2011. Vaccination with viral protein-mimicking peptides postpones mortality in domestic pigs infected by African swine fever virus. Mol. Med. Rep. 4:395-401. http://dx.doi.org/10.3892/mmr.2011.454.
62. Kollnberger SD, Gutierrez-Castaneda B, Foster-Cuevas M, Corteyn A, Parkhouse RM. 2002. Identification of the principal serological immunodeterminants of African swine fever virus by screening a virus cDNA library with antibody. J. Gen. Virol. 83:1331-1342.
63. Tekiel V, Alba-Soto CD, Gonzalez Cappa SM, Postan M, Sanchez DO. 2009. Identification of novel vaccine candidates for Chagas' disease by immunization with sequential fractions of a trypomastigote cDNA expression library. Vaccine 27:1323-1332. http://dx.doi.org/10.1016/j.vaccine.2008.12.056.